Omeros | OMER - الأصول





الأصول تغيير تاريخ
Adma Biologics USD 732.48M 48.28M 2026-09
Alnylam Pharmaceuticals USD 7.99B 2.44B 2026-09
BioMarin Pharmaceutical USD 11.57B 154.21M 2026-09
Cytokinetics USD 1.82B 99.77M 2026-09
Gilead Sciences USD 51.41B 2.05B 2026-09
Heron Therapeutics USD 230.45M 21.81M 2026-09
Immunic USD 189.74M 165.69M 2026-03
Insmed USD 2.23B 123.49M 2026-09
Knight Therapeutics CAD 1.05B 2.28M 2025-12
MacroGenics USD 345.41M 127.54M 2026-06
Omeros USD 200.57M 34.59M 2025-06
Pacira USD 34.68B 33.44B 2026-09
Pfizer USD 204.54B 3.41B 2026-09
Rockwell Medical USD 52.62M 1.34M 2025-06
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 3.17B 22.45M 2026-09
United Therapeutics USD 7.03B 186M 2026-09
Vertex Pharmaceuticals USD 32.74B 5.31B 2026-09